Neurocrine Biosciences (NBIX) Other Non Operating Income (2010 - 2022)
Neurocrine Biosciences (NBIX) posted Other Non Operating Income of -$70.0 million for Q2 2022, down 280.43% on a QoQ basis from -$18.4 million in Q4 2020.
Neurocrine Biosciences (NBIX) Other Non Operating Income (2010 - 2022) Analysis & Trends
Neurocrine Biosciences' Other Non Operating Income history runs 8 years deep, the most recent figure standing at -$70.0 million for Q2 2022.
- Quarterly Other Non Operating Income changed N/A year-over-year to -$70.0 million in Q2 2022, while the trailing twelve-month figure through Jun 2023 was -$70.0 million (changed 0.0% YoY) and the FY2022 annual result came in at -$70.0 million, changed N/A from the prior year.
- Other Non Operating Income was -$70.0 million for Q2 2022 at Neurocrine Biosciences, down from -$18.4 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at -$18.4 million in Q4 2020 and bottomed at -$70.0 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -70.00 Mn |
| Dec 31, 2020 | -18.40 Mn |
| Dec 31, 2015 | 20,000.00 |
| Dec 31, 2014 | 15,000.00 |
| Jun 30, 2014 | 3,000.00 |
| Dec 31, 2013 | 15,000.00 |
| Sep 30, 2013 | -5,000.00 |
| Jun 30, 2013 | 4,000.00 |
| Mar 31, 2013 | 2,000.00 |
| Dec 31, 2012 | 5,000.00 |
| Sep 30, 2012 | 2,000.00 |
| Jun 30, 2012 | 5,000.00 |
| Mar 31, 2012 | 2,000.00 |
| Dec 31, 2011 | 5,000.00 |
| Sep 30, 2011 | 18,000.00 |
| Jun 30, 2011 | 5,000.00 |
| Mar 31, 2011 | 8,000.00 |
| Dec 31, 2010 | 996,000.00 |
| Jun 30, 2010 | 35,000.00 |